{
    "clinical_study": {
        "@rank": "68986", 
        "arm_group": [
            {
                "arm_group_label": "Resveratrol nasal spray", 
                "arm_group_type": "Active Comparator", 
                "description": "2 sprays per nostril 3 times a day for a period of two months"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "2 sprays per nostril 3 times a day for a period of two months"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to evaluate whether treatment with a nasal spray based on\n      resveratrol has some benefit in patients with seasonal allergic rhinitis, mild, moderate, or\n      severe."
        }, 
        "brief_title": "Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic Rhinitis", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": "Seasonal Allergic Rhinitis", 
        "condition_browse": {
            "mesh_term": [
                "Rhinitis, Allergic, Seasonal", 
                "Rhinitis"
            ]
        }, 
        "detailed_description": {
            "textblock": "The aim of this study is to evaluate whether treatment with a nasal spray based on\n      resveratrol has some benefit in patients with seasonal allergic rhinitis, mild, moderate, or\n      severe. The primary objective is to assess whether the treatment with nasal spray based\n      resveratrol is able to improve the allergic rhinitis symptoms  during the two months of\n      treatment. The secondary aim is to evaluate if the resveratrol nasal spray is able to reduce\n      respiratory infections and wheezing episodes."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children of both sexes, ranging in age from 4 to 17 years\n\n          -  History of seasonal allergic rhinitis, mild, moderate or severe, defined according to\n             the ARIA guidelines in 2010, documented by recurrent episodes in the previous year\n             and confirmed by a positive skin test results\n\n          -  Written informed consent from at least one parent or a legal representative\n\n        Exclusion Criteria:\n\n          -  Lack of informed consent in writing by at least one parent or a legal representative\n\n          -  Concomitant disorders, such as infection of the upper (sinusitis, etc..) or lower\n             respiratory tract, nasal surgery in the last year, abnormalities of the respiratory\n             tract, immune diseases\n\n          -  Use of antihistamines, nasal or systemic corticosteroids, leukotriene modifiers,\n             cromolyn sodium, in the last six weeks"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "4 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02130440", 
            "org_study_id": "RESV_01"
        }, 
        "intervention": {
            "arm_group_label": [
                "Resveratrol nasal spray", 
                "Placebo"
            ], 
            "intervention_name": "Resveratrol nasal spray", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Resveratrol"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "nasal obstruction", 
            "sneezing", 
            "itching", 
            "rhinorrhea", 
            "respiratory infections", 
            "wheezing"
        ], 
        "lastchanged_date": "May 1, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Naples", 
                    "country": "Italy"
                }, 
                "name": "Second University of Naples"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic Rhinitis", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Nasal symptoms (itching, sneezing, rhinorrhea, and obstruction) will be scored by a four-point scale (0=no symptom; 1=mild; 2= moderate; 3= severe) and record by parents on a daily diary card.", 
            "measure": "Nasal symptom severity", 
            "safety_issue": "No", 
            "time_frame": "two years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02130440"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Second University of Naples", 
            "investigator_full_name": "Prof. Michele Miraglia del Giudice", 
            "investigator_title": "Prof. Michele Miraglia del Giudice", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The cough presence and severity will be assessed during the day and the night by four-point scale and recorded by parents on a daily diary card.", 
                "measure": "Cough", 
                "safety_issue": "No", 
                "time_frame": "two years"
            }, 
            {
                "description": "Wheezing will be assessed using the same four-point scale and record by parents on a daily diary card.", 
                "measure": "Wheezing", 
                "safety_issue": "No", 
                "time_frame": "two year"
            }, 
            {
                "description": "The albuterol use on demand will be record by parents on a daily diary card.", 
                "measure": "Albuterol use", 
                "safety_issue": "No", 
                "time_frame": "two years"
            }, 
            {
                "description": "The days with fever will be record by parents on a daily diary card.", 
                "measure": "Fever", 
                "safety_issue": "No", 
                "time_frame": "two years"
            }, 
            {
                "description": "School absences will be record by a diary card.", 
                "measure": "School absences", 
                "safety_issue": "No", 
                "time_frame": "two years"
            }, 
            {
                "description": "Evaluation of Cetirizine syrup on-demand use will be record by parents on a diary card", 
                "measure": "Antihistamines use", 
                "safety_issue": "No", 
                "time_frame": "two years"
            }, 
            {
                "description": "Emergency room visits for respiratory problems will be record by parents on a diary card.", 
                "measure": "Emergency visits", 
                "safety_issue": "No", 
                "time_frame": "two years"
            }
        ], 
        "source": "Second University of Naples", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Second University of Naples", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}